The Globe and Mail reports in its Wednesday, Oct. 4, edition that Neighbourly Pharmacy has agreed to be taken private by its largest shareholder, just two years after its initial public offerings. The Globe's Chris Hannay writes that Persistence Capital Partners (PCP), which already owns 50.2 per cent of common shares, has offered $20.50 a share, which values the company at $916-million. The offer is a 69-per-cent premium on Monday's closing price of $12.12 on the Toronto Stock Exchange, and about 21 per cent above the IPO price of $17 in May, 2021. It is also, however, about half of the stock's all-time closing high of $39.94 reached on Dec. 27, 2021. The deal gives PCP until Nov. 13 to arrange financing, and is also subject to a vote by shareholders. National Bank analyst Zachary Evershed said the deal was a "bitter pill" for investors who bought in through the highs of 2021, but thought the vote was likely to pass because the value was a "lifeline" for those who participated in the IPO and it was in line with peer transactions. The company disclosed in Tuesday's news release that it had hired TD Securities to give a fair market value for the company, which TD pegged between $20.50 to $25.50.